Prognostic Potential of Detection of WT1-mRNA in Acute Myeloid Leukemia
Not Applicable
Completed
- Conditions
- Acute myeloid leukemia (AML)
- Registration Number
- JPRN-jRCT1090220039
- Lead Sponsor
- Shuichi Miyawaki;Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Untreated, de novo AML patients, who are positive for WT1-mRNA at diagnosis and achieve complete remission after initial remission-induction therapy.
Exclusion Criteria
AML patients who do not meet the above condition.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method